Infinity Pharmaceuticals, Inc Earning Date (INFI)

USA |NASDAQ |USD

INFI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 14, 2022 Dec 2021 $-0.13 $-0.12 $-0.17
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 14, 2022 Dec 2021 $300.00K $428.00K $436.00K

Infinity Pharmaceuticals, Inc's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 2021.

INFI Earnings Date & History Chart

INFI Earnings & Revenue Forecast

INFI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 5 $-0.15 $-0.16 $-0.14
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 7 $-0.57 $-0.69 $-0.45

INFI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 1 / 0 $-0.14 $-0.14 $-0.15
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-0.58 $-0.58 $-0.61

INFI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 3 $380.00K $200.00K $520.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $1.53M $0.00 $2.25M

INFI Earnings Date & Revenue History

INFI Earnings History

|
Show More
Show More

INFI Revenue History

|
Show More
Show More

Infinity Pharmaceuticals, Inc Next Earnings Date & Report

INFI Next Earnings Date & Report Preview: Dec 2021 (FQ)

INFI's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 8 analysts, the average EPS estimation for Infinity Pharmaceuticals, Inc's next quarterly earnings is $-0.13, with a low EPS estimation of $-0.15, and a high estimation of $-0.13.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.13, the last 2 month trend is $-0.13, and the 3 month trend is $-0.14.

Based on 6 analysts, the average revenue estimation is $300.00K, with a low revenue estimation of $0.00, and a high estimation of $550.00K.

Infinity Pharmaceuticals, Inc Previous Earnings Dates & Reports

INFI Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Infinity Pharmaceuticals, Inc's previous earnings date was Nov 2, 2021 for its fiscal quarter ended Sep 30, 2021.

INFI's earnings per share (EPS) was $-0.12, beating the consensus analysts forecast of $-0.14 by 13.36%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -7.69%, and higher than the same period a year before (Sep 2020) by -25.00%.

Revenues were $428.00K, worse than the forecast of $520.00K by -17.69%, down by -16.41% from the previous quarter , and down by -13.71% from the same period last year.

The company reported a net income of $-10.71M.

Free cash flow for the quarter was $-7.87M , compared to $-9.57M last quarter and $-7.88M a year before.

INFI ended the quarter with $51.42M in total debt, a decrease of -0.52% compared to the previous quarter, and an increase of 1.75% compared to the same quarter a year before.

INFI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Infinity Pharmaceuticals, Inc's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.

INFI's earnings per share (EPS) was $-0.68, missing the consensus analysts forecast of $-0.67 by 1.49% , and higher than the previous year's EPS (Dec 2019) by -17.07%.

Revenues were $1.72M, better than the forecast of $1.52M by 13.09%, and down by -43.62% from previous year's revenue.

The company reported a net income of $-40.49M.

Infinity Pharmaceuticals, Inc reported a free cash flow of $-35.78M for its fiscal year, compared to $-43.86M a year ago.

The company ended the fiscal year with $52.35M in total debt, an increase of 74.47% compared to the previous year.